Xolair 150 MG/ML 1S
Ended Awarded
- Contract number
- SPE2DX25FKVXP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $49,025
Award facts
- Contract value 100% obligated
- $49,025.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $49,025.13 for XOLAIR 150 mg/ml on August 21, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The contract carries no set-aside designation and will be performed in Park Ridge, Illinois, with an ultimate completion date of September 10, 2025. XOLAIR (omalizumab) is a biologic medication used to treat moderate-to-severe allergic asthma and other allergic conditions, making this delivery order part of the company's ongoing pharmaceutical supply mission to Defense Logistics Agency medical supply operations.
This award reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of specialty medications and biologics to Department of Defense healthcare facilities. The company's comprehensive contract portfolio demonstrates consistent success in competing for federal pharmaceutical procurement without set-aside designations, leveraging its woman-owned small business status and expertise in managing complex pharmaceutical inventories. The delivery order supports the Medical Supply Chain function within defense operations, ensuring military health facilities have access to essential specialty pharmaceutical products.
Quick answers
Who was awarded contract SPE2DX25FKVXP?
SPE2DX25FKVXP was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 21, 2025.
How much is contract SPE2DX25FKVXP worth?
The government has obligated $49,025 on SPE2DX25FKVXP.
Is contract SPE2DX25FKVXP an order under another contract?
Yes. SPE2DX25FKVXP is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVXP competed?
The extent of competition for SPE2DX25FKVXP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award